Disease: Mastocytosis, Systemic ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0221013
Disease: Mastocytosis, Systemic
Mastocytosis, Systemic 		0.030 Biomarker disease BEFREE In conclusion, these preclinical studies identified CD203c as a novel therapeutic target on neoplastic MCs, and AGS-16C3F as a promising ADC for the treatment of patients with AdvSM. 30804017 2019
CUI: C0221013
Disease: Mastocytosis, Systemic
Mastocytosis, Systemic 		0.030 AlteredExpression disease BEFREE Other surface molecules, such as CD63 or CD203c, are overexpressed on neoplastic MC in SM, and are further upregulated upon cross-linking of the IgE receptor. 21112036 2010
CUI: C0221013
Disease: Mastocytosis, Systemic
Mastocytosis, Systemic 		0.030 AlteredExpression disease BEFREE In conclusion, CD203c is a novel activation-linked surface antigen on MC that is upregulated in response to IgE receptor cross-linking and is overexpressed on neoplastic MC in patients with SM. 19144265 2009